Psychedelic trials face downsides of the 'trip'.

Recent research efforts are developing methods to disentangle the influence of participant expectations from the direct pharmacological effects of psychedelic substances in clinical trials. This work addresses a key methodological challenge in psychedelic research, where the intense subjective experiences and cultural narratives surrounding these drugs can powerfully shape participant beliefs and outcomes. By designing studies that better isolate the drug's specific effects, scientists hope to obtain clearer evidence on the therapeutic potential of psychedelics, independent of the placebo response and expectancy biases that complicate interpretation of trial results.

Study at a glance

Abstract

New studies aim to separate participant expectations from drug effects.